GENE ONLINE|News &
Opinion
Blog

2022-07-28| R&DTechnology

Why Cells Move Faster Through Mucus Than Blood

by Joy Lin
Share To

At John Hopkins University, two researchers, Matthew Pittman and Yun Chen, discovered something curious about the movement of cancer cells

Pittman, a PhD student, had made a mucus-like polymer solution to see how different cell types move through them, and saw that cancer cells migrated faster than non-cancerous cells through the viscous fluid. This prompted Chen, an assistant professor in the Department of Mechanical Engineering, to reach out to Sergey Plotnikov, an assistant professor in the Department of Cells and Systems Biology at the University of Toronto who studied the push and pull of cell movement. 

Shifting Gears in Different Environments

Plotnikov was amazed at the change of speed cancer cells displayed in the thick fluid. Normally, researchers look for slow, subtle changes under the microscope, he reasoned, but what they saw were cells moving twice as fast in real time, and spreading to double their original size. 

Together with Earnest Iu, a PhD student in the same department, Plotnikov used advanced microscopy techniques to measure the traction cells exert to move, as well as changes in their structural molecules. Besides cancer cells, they also looked at fibroblasts, both of which have ruffled edges as opposed to cells with smooth edges. Through experiment, they determined that ruffled cell edges sense viscosity in the environment to trigger a response that allows the cell to pull through the resistance — by flattening ruffles, spreading out and latching onto the surrounding surfaces.

Related Article: Monoclonal Antibody Discovered to Potentially Act Against All Coronaviruses

Stabilizing Actin and Spreading Across Thickened Environments

At first, Plotnikov and Iu thought stopping myosin proteins, which help muscles contract, would slow cell spreading. However, this did not prove to be the case as the cells still sped up. They instead found that columns of actin protein inside the cell, which also help muscles contract, respond to the thickened fluid to become more stable to push out the edge of the cell. 

The researchers’ combined results suggest that viscosity in the extracellular environment plays an important role in disease, and may help explain tumor progression, scarring in mucus-filled lungs affected by cystic fibrosis, and the wound healing process.

Tumors create a viscous environment, helping spreading cells move into the tumor more quickly. The development of ruffled edges in cancer cells may contribute to metastasis, the researchers surmised. 

On the other hand, targeting the spreading response in fibroblasts may reduce tissue damage in the mucus-filled lungs affected by cystic fibrosis. As ruffled fibroblasts move more quickly than other cells through the mucus, they may initiate scarring at the site of the wound instead of healing.  By changing the viscosity of the lung’s mucus, one may be able to control cell movement.

“For example, perhaps if you put a liquid as thick as honey into a wound, the cells will move deeper and faster into it, thereby healing it more effectively,” inserted Plotnikov.

The findings cumulated in a paper titled “Membrane ruffling is a mechanosensor of extracellular fluid viscosity”, which was published in Nature Physics

Next, the scientists will investigate how to slow the movement of ruffled cells through thickened environments, which may pave the way for new treatments that target cancer and cystic fibrosis.

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Pfizer Partners with Renowned Life Sciences VC to Build Pipeline Projected to be Worth $7 Billion
2023-07-20
Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy
2022-09-15
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top